Drugs / KQB168
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06994806 | Jun 2025 → Nov 2027 expected | — | Kumquat Biosciences Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | KQB168 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06994806 ↗ |
| Route | Oral | “Oral KQB168” NCT06994806 ↗ |